MCC950 is a small molecule inhibitor of NLRP3 that can alleviate a variety of inflammasome‐related diseases, including cryopyrin‐associated periodic syndrome (CAPS), experimental autoimmune encephalomyelitis (EAE), type 2 diabetes, and Alzheimer's disease (AD).191. The gene discussed is NLRP3; the disease is type 2 diabetes mellitus.